Firefly Neuroscience, Inc.
AIFF
$3.20
-$0.01-0.31%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -301.84% | -217.31% | -- | -- | -- |
Total Depreciation and Amortization | -- | -- | -- | -- | -- |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 1,185.76% | 930.42% | -- | -- | -- |
Change in Net Operating Assets | 227.21% | -725.76% | -- | -- | -- |
Cash from Operations | -183.38% | -157.66% | -- | -- | -- |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 14.77% | -- | -- | -- | -- |
Cash from Investing | -23.58% | -- | -- | -- | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -6.44% | 1,986.16% | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -60.03% | -60.03% | -- | -- | -- |
Repurchase of Preferred Stock | 60.03% | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 35.67% | 139.73% | -- | -- | -- |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -115.97% | -46.25% | -- | -- | -- |